Y10S977/748

DISCRETE CARBON NANOTUBES WITH TARGETED OXIDATION LEVELS AND STABLE GEL FORMULATIONS THEREOF

Discrete, individualized carbon nanotubes having targeted, or selective, oxidation levels and/or content on the interior and exterior of the tube walls are claimed. Such carbon nanotubes can have little to no inner tube surface oxidation, or differing amounts and/or types of oxidation between the tubes' inner and outer surfaces. These new discrete carbon nanotubes are useful in plasticizers, which can then be used as an additive in compounding and formulation of elastomeric, thermoplastic and thermoset composite for improvement of mechanical, electrical and thermal properties.

DEGRADABLE CARBON NANOTUBE-CONTAINING BIOSENSORS AND METHODS FOR TARGET CLINICAL MARKER DETECTION

The invention relates to carbon nanotube-containing composites as biosensors to detect the presence of target clinical markers, methods of their preparation and uses in the medical field. The invention is particularly suitable for the detection in patient biological specimens of bone markers and tissue markers. The biosensors of the invention include carbon nanotubes deposited on a substrate, gold nanoparticles deposited on the carbon nanotubes and, binder material and biomolecule deposited on the gold-coated carbon nanotubes. The biomolecule is selected to interact with the target clinical markers. The biosensor can be used as an in-situ or an ex-situ device to detect and measure the presence of the target clinical markers.

Degradable carbon nanotube-containing biosensors and methods for target clinical marker detection

The invention relates to carbon nanotube-containing composites as biosensors to detect the presence of target clinical markers, methods of their preparation and uses in the medical field. The invention is particularly suitable for the detection in patient biological specimens of bone markers and tissue markers. The biosensors of the invention include carbon nanotubes deposited on a substrate, gold nanoparticles deposited on the carbon nanotubes and, binder material and biomolecule deposited on the gold-coated carbon nanotubes. The biomolecule is selected to interact with the target clinical markers. The biosensor can be used as an in-situ or an ex-situ device to detect and measure the presence of the target clinical markers.

EPOXY RESIN COMPOSITES

The present invention relates to epoxy/nanotube composites. The composites have at least one epoxy resin. The composites also have a plurality of discrete oxidized carbon nanotubes. The nanotubes have an aspect ratio of from about 25 to about 250. The epoxy/nanotube composite may be bonded or adhered to a substrate.

FOAM STRUCTURE WITH NOMINALLY-ALIGNED ARRAYS OF CARBON NANOTUBES
20170029274 · 2017-02-02 ·

A foam structure with nominally aligned arrays of carbon nanotube is described. The foam structure also includes a functionalization substance associated or attached to carbon nanotube surfaces.